Transient Responses to NOTCH and TLX1/HOX11 Inhibition in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
2011
Inhibition of TLX1 and NOTCH in T-Cell Acute Lymphoblastic Leukemia
Sample size: 7
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Lesley A. Rakowski, Erica A. Lehotzky, Mark Y. Chiang
Primary Institution: University of Michigan
Hypothesis
Can TLX1 and NOTCH inhibition improve treatment strategies for T-cell acute lymphoblastic leukemia?
Conclusion
Inhibiting TLX1 and NOTCH can delay leukemia progression, but the effects are transient.
Supporting Evidence
- TLX1 inhibition reduced leukemia growth by 28%.
- NOTCH inhibition extended median survival by 17 days.
- TLX1 and NOTCH inhibition together increased apoptosis in leukemia cells.
Takeaway
This study shows that blocking certain genes can help slow down a type of blood cancer in mice, but it doesn't completely stop it.
Methodology
The study used a conditional doxycycline-regulated mouse model to test the effects of TLX1 and NOTCH inhibition on leukemia progression.
Limitations
The effects of inhibiting TLX1 and NOTCH were only temporary, and tumors eventually escaped inhibition.
Statistical Information
P-Value
0.0439
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website